905 related articles for article (PubMed ID: 17699011)
1. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
2. Major lipids, apolipoproteins, and risk of vascular disease.
; Di Angelantonio E; Sarwar N; Perry P; Kaptoge S; Ray KK; Thompson A; Wood AM; Lewington S; Sattar N; Packard CJ; Collins R; Thompson SG; Danesh J
JAMA; 2009 Nov; 302(18):1993-2000. PubMed ID: 19903920
[TBL] [Abstract][Full Text] [Related]
3. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
[TBL] [Abstract][Full Text] [Related]
4. Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study.
Sondermeijer BM; Rana JS; Arsenault BJ; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
Eur J Clin Invest; 2013 Oct; 43(10):1009-15. PubMed ID: 23859101
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years.
Simons LA; Simons J; Friedlander Y; McCallum J
Atherosclerosis; 2001 Nov; 159(1):201-8. PubMed ID: 11689222
[TBL] [Abstract][Full Text] [Related]
6. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
8. Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women.
Dugani SB; Moorthy MV; Li C; Demler OV; Alsheikh-Ali AA; Ridker PM; Glynn RJ; Mora S
JAMA Cardiol; 2021 Apr; 6(4):437-447. PubMed ID: 33471027
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
11. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
14. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
[TBL] [Abstract][Full Text] [Related]
15. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
[TBL] [Abstract][Full Text] [Related]
16. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
Kastelein JJ; van der Steeg WA; Holme I; Gaffney M; Cater NB; Barter P; Deedwania P; Olsson AG; Boekholdt SM; Demicco DA; Szarek M; LaRosa JC; Pedersen TR; Grundy SM; ;
Circulation; 2008 Jun; 117(23):3002-9. PubMed ID: 18519851
[TBL] [Abstract][Full Text] [Related]
17. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
[TBL] [Abstract][Full Text] [Related]
18. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
[TBL] [Abstract][Full Text] [Related]
19. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
20. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
